Evidence map›Paper›PMID 33739476›Full record

ArticleAddiction (Abingdon, England)2021

Opioid use disorder and overdose among youth following an initial opioid prescription.

Scott E Hadland, Sarah M Bagley, Mam Jarra Gai, Joel J Earlywine, Samantha F Schoenberger, Jake R Morgan, Joshua A Barocas

Open access · greenAbstract read
In one paragraph

Article in Addiction (Abingdon, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Evidence Base on Outpatient Behavioral Treatments for Adolescent Substance Use, Update 2018-2023: Current Status, Best Practices, and Opportunities for Advancing the Science.Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Scott E HadlandDivision of General Pediatrics, Department of Pediatrics, Boston University School of Medicine, Boston, MA, USA.ORCID 0000-0003-3189-6199
Sarah M BagleyDivision of General Pediatrics, Department of Pediatrics, Boston University School of Medicine, Boston, MA, USA.ORCID 0000-0002-7524-0178
Mam Jarra GaiSection of Infectious Diseases, Department of Medicine, Boston Medical Center, Boston, MA, USA.
Joel J EarlywineDepartment of Health Law, Policy, and Management, Boston University School of Public Health, Boston, MA, USA.
Samantha F SchoenbergerSection of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA, USA.ORCID 0000-0002-9401-2998
Jake R MorganDepartment of Health Law, Policy, and Management, Boston University School of Public Health, Boston, MA, USA.ORCID 0000-0002-1559-3983
Joshua A BarocasSection of Infectious Diseases, Department of Medicine, Boston Medical Center, Boston, MA, USA.
Boston University · USBoston Medical Center · US

Funding

Researching Effective Strategies to Prevent Opioid Death (RESPOND)R01DA046527 · NIDA · BOSTON MEDICAL CENTER · PI Benjamin P. Linas · 2018 to 2026
$7.2M
Collaborative Care Office-Based Opioid Treatment for Adolescents and Young AdultsK23DA045085 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI HADLAND, SCOTT EVAN · 2018 to 2022
$1.1M
A Behavioral Intervention to Engage Emerging Adults in Addiction Treatment after a Non-fatal Opioid OverdoseK23DA044324 · NIDA · BOSTON MEDICAL CENTER · PI BAGLEY, SARAH M · 2017 to 2021
$938k
NIDA NIH HHS K23 DA044324NIDA NIH HHS K23 DA045085NIDA NIH HHS L40 DA042434NIDA NIH HHS R01 DA046527
6 · The paper itself

Abstract

BACKGROUND AND

aimsSome adolescents and young adults (termed "youth") prescribed an opioid will develop opioid use disorder or experience overdose. This study aimed to identify patient and prescription characteristics associated with subsequent risk of opioid use disorder or overdose during the year after an opioid is first dispensed.

designRetrospective cohort study.

settingCommercial health insurance claims in a large United States (US) database from 2006 to 2016.

participantsYouth age 11 to 25 years filling an initial opioid prescription (n = 3 278 990). MEASUREMENTS: The primary outcome was development of an 'opioid-related complication' (a diagnosis of opioid use disorder or opioid-related overdose) during the subsequent 12 months. Exposures of interest were patient (sociodemographic information, and physical and mental health diagnoses) and prescription characteristics (opioid formulation, dose, and duration).

findingsAmong youth filling an initial opioid prescription, median age was 18 years (interquartile range [IQR] = 16-21) and 56.1% were female. During the subsequent 12 months, 10 405 (0.3%) youth experienced an opioid-related complication. Conditions associated with increased risk included mood/anxiety disorders (adjusted relative risk [aRR] = 4.45; 95% CI = 4.25-4.66) and substance use (aRR = 20.77; 95% CI = 19.74-21.84). Comorbid substance use disorders were present among 72.8% of youth experiencing an opioid-related complication and included alcohol (33.4%), cannabis (33.0%), nicotine (43.2%), and other substance use disorders (75.5%). Long-acting opioids (aRR = 2.59; 95% CI = 2.18-3.09) and longer durations were associated with increased risk (7-14 days: aRR = 1.15; 95% CI = 1.08-1.22; ≥15 days: aRR = 1.96; 95% CI = 1.80-2.12) compared with short-acting formulations and durations ≤3 days, respectively.

conclusionsAmong United States youth, complications after an initial opioid prescription appear to be relatively rare and appear to be associated with mood/anxiety disorders, substance use, comorbid substance use disorders, and prescriptions involving long-acting opioids or long durations.

Indexed as

Drug OverdoseOpioid-Related DisordersAdolescentAdultAnalgesics, OpioidChildFemaleHumansInfant, NewbornPrescriptionsRetrospective StudiesUnited StatesYoung AdultAnalgesics, OpioidAdolescentmental healthopioid-related disordersprescriptionssubstance-related disordersyoung adult

Identifiers

PMID33739476
PMCPMC8429061
OpenAlexW3139058674

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.